Antonio Fontanellas
-
- Neonatal Health and Biochemistry 37
- Molecular Biology top 10%
- Porphyrin Metabolism and Disorders 66
- Heme Oxygenase-1 and Carbon Monoxide 50
- CRISPR and Genetic Engineering 5
- Rheumatology top 5%
- Folate and B Vitamins Research 12
- Genetics top 5%
- Virus-based gene therapy research 10
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 10
-
- Methemoglobinemia and Tumor Lysis Syndrome 6
- Co-authors
- Rafael Enrı́quez de SalamancaPedro BerraondoMatías A. ÁvilaHubert de VerneuilJesús PrìetoAna SampedroPaolo G.V. MartiniItsaso Mauleón
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Antonio Fontanellas
86 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Pediatrics, Perinatology and Child Health 316
- Molecular Biology 1.0k
- Rheumatology 194
- Genetics 343
- Clinical Biochemistry 62
Countries citing papers authored by Antonio Fontanellas
This map shows the geographic impact of Antonio Fontanellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Fontanellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Fontanellas more than expected).
Fields of papers citing papers by Antonio Fontanellas
This network shows the impact of papers produced by Antonio Fontanellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Fontanellas. The network helps show where Antonio Fontanellas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Fontanellas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 12 | |
| 6 | 2022 | 12 | |
| 7 | 2019 | 87 | |
| 8 | 2016 | 22 | |
| 9 | 2015 | 2 | |
| 10 | 2015 | 13 | |
| 11 | 2014 | 7 | |
| 12 | 2010 | 24 | |
| 13 | 2009 | 7 | |
| 14 | 2005 | 9 | |
| 15 | Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. | 2002 | 23 |
| 16 | 2002 | 12 | |
| 17 | 1999 | 94 | |
| 18 | 1998 | 45 | |
| 19 | 1994 | 20 | |
| 20 | 1993 | 3 |
About Antonio Fontanellas
Antonio Fontanellas is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Biochemistry and Molecular Biology, having authored 86 papers that have together received 1.4k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (66 papers), Heme Oxygenase-1 and Carbon Monoxide (50 papers), Neonatal Health and Biochemistry (37 papers), Folate and B Vitamins Research (12 papers), Virus-based gene therapy research (10 papers), Metabolism and Genetic Disorders (10 papers), Methemoglobinemia and Tumor Lysis Syndrome (6 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (316 citations), Molecular Biology (1.0k citations) and Rheumatology (194 citations). Antonio Fontanellas has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Rafael Enrı́quez de Salamanca, Pedro Berraondo, Matías A. Ávila, Hubert de Verneuil, Jesús Prìeto, Ana Sampedro, Paolo G.V. Martini, Itsaso Mauleón, Frédéric Mazurier and Gloria González‐Aseguinolaza. Their work appears in journals such as Blood, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.